Molecular BiologybioRxivPreprint
A metabolic perspective on eIF1A and eIF3B inhibition as a potential therapeutic strategy in psoriasis
Natalie Bordag, Benjamin M. R. Bourgeois, Tobias Madl…·Nicole Golob‐Schwarzl
This study investigates the metabolic effects of eIF1A and eIF3B inhibition in psoriasis models, finding context-dependent metabolic changes and therapeutic benefits.
DOI 10.64898/2026.10.08.757342